Asherson, G. L.
June 1965
British Medical Journal;6/12/1965, Vol. 1 Issue 5449, p1546
Book Review
No abstract available.


Related Articles

  • Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemia. So, A.; Brenner, M.K.; Hill, I.D.; Asherson, G.L.; Webster, A.D.B. // British Medical Journal (Clinical Research Edition);11/3/1984, Vol. 289 Issue 6453, p1177 

    Examines the effectiveness of intravenous gammaglobulin treatment in patients with hypogammaglobulinemia in England. Comparison of the treatment with standard intramuscular preparation; Treatment of patients through gammaglobulin and intramuscular preparation; Suggestion to use gammaglobulin...

  • High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia. von Dem Borne, A.E.G. KR.; Vos, J.J.E.; Pegels, J.G.; Thomas, L.L.M.; van Der Lelie, H. // British Medical Journal (Clinical Research Edition);1/23/1988, Vol. 296 Issue 6617, p249 

    Compares the efficacy between methylprednisolone and gammaglobulin for the treatment of autoimmune thrombocytopenia in Netherlands. Mechanism of intravenous gammaglobulin; Effectiveness of methylprednisolone in terms of the frequency of response; Variability in the effects of corticosteroids...

  • gamma-globulin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p330 

    An encyclopedia entry for "gamma-globulin" is presented. It refers to a substance containing antibodies against a specific infection. Injections of gamma-globulins are said to provide temporary protection against illnesses such as chickenpox and tetanus.

  • Kawasaki syndrome: lessons for Britain. Bissenden, J.G. // BMJ: British Medical Journal (International Edition);4/21/90, Vol. 300 Issue 6731, p1025 

    Examines the diagnosis and treatment of Kawasaki syndrome in Great Britain. Characteristic features of the disease; Complication of the disease; Effectiveness of gammaglobulin and aspirin treatment.

  • Antibody Against the Human Immunodeficiency Virus in Commercial Intravenous Gammaglobulin Preparations. Wood, Chester C.; Williams, Alan E.; McNamara, James G.; Annunziata, Josephine A.; Feorino, Paul M.; Conway, Christopher O. // Annals of Internal Medicine;Oct86, Vol. 105 Issue 4, p536 

    Presents a study which determined the antibody levels against HIV in intravenous gammaglobulin preparations. Methods; Results; Discussion.

  • Gammaglobulin.  // Reactions Weekly;1/7/2012, Issue 1383, p21 

    The article describes the case of a baby girl who developed precursor B-lymphoblastic lymphoma following treatment with gammaglobulin.

  • Therapy for Guillain-Barre syndrome. Chalk, C.H.; Dyck, P.J. // Cortlandt Forum;8/25/96, Vol. 9 Issue 8, p24 

    Presents a treatment guideline for Guillain-Barre syndrome in the United States. Intravenous gamma-globulin; Treatment duration.

  • Intravenous Immunoglobulin for Guillain-Barré Syndrome: How Effective? Ali Tasdemir, Haydar; Dilber, Cergiz; Kanvber, Yilmaz; Uysal, Serap // Journal of Child Neurology;Nov2006, Vol. 21 Issue 11, p972 

    Guillain-Barré syndrome is an acute inflammatory demyelinating neuropathy characterized by progressive symmetric polyradiculoneuritis, predominantly manifested by weakness and areflexia. In this article, we report our findings in 25 children treated with intravenous immunoglobulin and compare...

  • A single point mutation is the cause of the Greek form of hereditary persistence of fetal... Berry, Meera; Grosveld, Frank // Nature;8/6/1992, Vol. 358 Issue 6386, p499 

    Focuses on cases of hereditary persistence of fetal hemoglobin (HPFH). Tests whether the point mutation found in the Greek non-deletion HPFH is the cause of raised gamma-globulin levels in the adult stage. Ability of raised levels of gamma-globulin to alleviate beta-thalassemia in sickle cell...

  • High-titre hepatitis B immune globulin.  // British Medical Journal;1/31/1976, Vol. 1 Issue 6004, p241 

    Examines the efficacy of gammaglobulin in preventing type A hepatitis. Signs and symptoms of the disease; Treatment and management of the disease process; Increase of the titer of antibody to the hepatitis B surface antigen.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics